EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation.

J Oncol · 2021 · PMC8610726 · PMID 34824583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Therefore, it is extremely significant to explore the underlying pathogenesis and discover immune biomarkers to diagnose, treat, and predict the prognosis of GBM.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.